|
[1]
|
Special Issue “Targeted Therapy of Cancer: Innovative Drugs and Molecular Tools”
International Journal of Molecular Sciences,
2026
DOI:10.3390/ijms27020657
|
|
|
|
|
[2]
|
Cobalamin Metabolism Is a Key Process of Breast Cancer Cells That Offers New Ways for Diagnosis and Treatment
Scientia Pharmaceutica,
2026
DOI:10.3390/scipharm94010018
|
|
|
|
|
[3]
|
CD320 Receptor and Vitamin B12 as Potential Targets for Anti-Cancer Therapy
International Journal of Molecular Sciences,
2025
DOI:10.3390/ijms26125652
|
|
|
|
|
[4]
|
Fuelling the Fight from the Gut: Short-Chain Fatty Acids and Dexamethasone Synergise to Suppress Gastric Cancer Cells
Cancers,
2025
DOI:10.3390/cancers17152486
|
|
|
|
|
[5]
|
TCBIR/CD320: a potential therapeutic target upregulated in endothelial cells and associated with immune cell infiltration in liver hepatocellular carcinoma
Discover Oncology,
2024
DOI:10.1007/s12672-024-01122-w
|
|
|
|
|
[6]
|
Deciphering the heterogeneity and immunosuppressive function of regulatory T cells in osteosarcoma using single-cell RNA transcriptome
Computers in Biology and Medicine,
2023
DOI:10.1016/j.compbiomed.2023.107417
|
|
|
|
|
[7]
|
Generation of nanobodies targeting the human, transcobalamin‐mediated vitamin B
12
uptake route
The FASEB Journal,
2022
DOI:10.1096/fj.202101376RR
|
|
|
|
|
[8]
|
Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells
The FASEB Journal,
2021
DOI:10.1096/fj.202000197R
|
|
|
|
|
[9]
|
Cellular uptake of vitamin B12: Role and fate of TCblR/CD320, the transcobalamin receptor
Experimental Cell Research,
2020
DOI:10.1016/j.yexcr.2020.112256
|
|
|
|
|
[10]
|
Vitamin B12-conjugated sericin micelles for targeting CD320-overexpressed gastric cancer and reversing drug resistance
Nanomedicine,
2019
DOI:10.2217/nnm-2018-0321
|
|
|
|
|
[11]
|
CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma
Oncotarget,
2017
DOI:10.18632/oncotarget.22131
|
|
|
|
|
[12]
|
Structural basis of transcobalamin recognition by human CD320 receptor
Nature Communications,
2016
DOI:10.1038/ncomms12100
|
|
|
|